266 related articles for article (PubMed ID: 17460151)
1. Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-Jun NH2 terminal kinase inhibitor SP600125.
Williams AS; Issa R; Leung SY; Nath P; Ferguson GD; Bennett BL; Adcock IM; Chung KF
J Pharmacol Exp Ther; 2007 Jul; 322(1):351-9. PubMed ID: 17460151
[TBL] [Abstract][Full Text] [Related]
2. Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125.
Nath P; Eynott P; Leung SY; Adcock IM; Bennett BL; Chung KF
Eur J Pharmacol; 2005 Jan; 506(3):273-83. PubMed ID: 15627438
[TBL] [Abstract][Full Text] [Related]
3. JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages.
Nieminen R; Lahti A; Jalonen U; Kankaanranta H; Moilanen E
Int Immunopharmacol; 2006 Jun; 6(6):987-96. PubMed ID: 16644485
[TBL] [Abstract][Full Text] [Related]
4. A c-Jun NH2-terminal kinase inhibitor SP600125 (anthra[1,9-cd]pyrazole-6 (2H)-one) blocks activation of pancreatic stellate cells.
Masamune A; Kikuta K; Suzuki N; Satoh M; Satoh K; Shimosegawa T
J Pharmacol Exp Ther; 2004 Aug; 310(2):520-7. PubMed ID: 15056726
[TBL] [Abstract][Full Text] [Related]
5. Streptococcus pneumoniae induced c-Jun-N-terminal kinase- and AP-1 -dependent IL-8 release by lung epithelial BEAS-2B cells.
Schmeck B; Moog K; Zahlten J; van Laak V; N'Guessan PD; Opitz B; Rosseau S; Suttorp N; Hippenstiel S
Respir Res; 2006 Jul; 7(1):98. PubMed ID: 16834785
[TBL] [Abstract][Full Text] [Related]
6. Role of p38 mitogen-activated protein kinase in ozone-induced airway hyperresponsiveness and inflammation.
Williams AS; Issa R; Durham A; Leung SY; Kapoun A; Medicherla S; Higgins LS; Adcock IM; Chung KF
Eur J Pharmacol; 2008 Dec; 600(1-3):117-22. PubMed ID: 18926814
[TBL] [Abstract][Full Text] [Related]
7. c-Jun NH2-terminal kinase is crucially involved in renal tubulo-interstitial inflammation.
de Borst MH; Prakash J; Sandovici M; Klok PA; Hamming I; Kok RJ; Navis G; van Goor H
J Pharmacol Exp Ther; 2009 Dec; 331(3):896-905. PubMed ID: 19717791
[TBL] [Abstract][Full Text] [Related]
8. SP600125 promotes resolution of allergic airway inflammation via TLR9 in an OVA-induced murine acute asthma model.
Wu HM; Fang L; Shen QY; Liu RY
Mol Immunol; 2015 Oct; 67(2 Pt B):311-6. PubMed ID: 26139014
[TBL] [Abstract][Full Text] [Related]
9. Effect of an inhibitor of Jun N-terminal protein kinase, SP600125, in single allergen challenge in sensitized rats.
Eynott PR; Xu L; Bennett BL; Noble A; Leung SY; Nath P; Groneberg DA; Adcock IM; Chung KF
Immunology; 2004 Jul; 112(3):446-53. PubMed ID: 15196213
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of JNK enhances TGF-beta1-activated Smad2 signaling in mouse embryonic lung.
Wu S; Kasisomayajula K; Peng J; Bancalari E
Pediatr Res; 2009 Apr; 65(4):381-6. PubMed ID: 19127219
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 mediates thermal injury-induced lung damage through C-Jun NH2-terminal kinase signaling.
Chen LW; Chang WJ; Wang JS; Hsu CM
Crit Care Med; 2007 Apr; 35(4):1113-22. PubMed ID: 17334237
[TBL] [Abstract][Full Text] [Related]
12. SP600125, an inhibitor of c-Jun NH2-terminal kinase, blocks expression of angiotensin II-induced monocyte chemoattractant protein-1 in human mesangial cells.
Ding GX; Zhang AH; Huang SM; Pan XQ; Chen RH
World J Pediatr; 2010 May; 6(2):169-76. PubMed ID: 20490773
[TBL] [Abstract][Full Text] [Related]
13. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.
Han Z; Boyle DL; Chang L; Bennett B; Karin M; Yang L; Manning AM; Firestein GS
J Clin Invest; 2001 Jul; 108(1):73-81. PubMed ID: 11435459
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of c-Jun N-terminal kinase sensitizes tumor cells to flavonoid-induced apoptosis through down-regulation of JunD.
Kook SH; Son YO; Jang YS; Lee KY; Lee SA; Kim BS; Lee HJ; Lee JC
Toxicol Appl Pharmacol; 2008 Mar; 227(3):468-76. PubMed ID: 18078968
[TBL] [Abstract][Full Text] [Related]
15. An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins.
Takamura M; Matsuda Y; Yamagiwa S; Tamura Y; Honda Y; Suzuki K; Ichida T; Aoyagi Y
Life Sci; 2007 Mar; 80(14):1335-44. PubMed ID: 17300814
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis.
Minutoli L; Altavilla D; Marini H; Passaniti M; Bitto A; Seminara P; Venuti FS; Famulari C; Macrì A; Versaci A; Squadrito F
Life Sci; 2004 Oct; 75(24):2853-66. PubMed ID: 15454338
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB.
Wong CK; Cheung PF; Ip WK; Lam CW
Am J Respir Cell Mol Biol; 2005 Aug; 33(2):186-94. PubMed ID: 15860795
[TBL] [Abstract][Full Text] [Related]
18. Ozone exposure triggers insulin resistance through muscle c-Jun N-terminal kinase activation.
Vella RE; Pillon NJ; Zarrouki B; Croze ML; Koppe L; Guichardant M; Pesenti S; Chauvin MA; Rieusset J; Géloën A; Soulage CO
Diabetes; 2015 Mar; 64(3):1011-24. PubMed ID: 25277399
[TBL] [Abstract][Full Text] [Related]
19. Peptidoglycan induces interleukin-6 expression through the TLR2 receptor, JNK, c-Jun, and AP-1 pathways in microglia.
Lin HY; Tang CH; Chen JH; Chuang JY; Huang SM; Tan TW; Lai CH; Lu DY
J Cell Physiol; 2011 Jun; 226(6):1573-82. PubMed ID: 20945380
[TBL] [Abstract][Full Text] [Related]
20. Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP600125 in a mouse model of NSAID-associated enteropathy.
Ramirez-Alcantara V; LoGuidice A; Boelsterli UA
Am J Physiol Gastrointest Liver Physiol; 2009 Nov; 297(5):G990-8. PubMed ID: 20501447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
